PMV Pharmaceuticals (PMVP)

• Market cap: $60.7M
• 1 day: 0%
• 5 days: -6.56%
• 1 month: -5%
• 3 months: -20.83%
• 6 months: -14.29%
• Year to date: -7.32%
• 1 year: -17.99%
• 5 years: -97.42%
• 10 years: -96.96%
• Sector: Healthcare
• Industry: Biotechnology

About: PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which can eliminate cancer cells. Its pipeline rezatapopt PYNNACLE, rezatapopt and azacitidine, rezatapopt (PC14586), and PMV-586-101.

Employees: 47